Ignite Creation Date:
2024-05-06 @ 2:04 PM
Last Modification Date:
2024-10-26 @ 1:24 PM
Study NCT ID:
NCT04202627
Status:
COMPLETED
Last Update Posted:
2023-03-29
First Post:
2019-12-11
Brief Title:
Biomarker Development in LGMD2i
Sponsor:
Organization:
ML Bio Solutions Inc
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
Blood and Tissue samples will be taken for biomarker development and retained for future research No clinical diagnosis will be given to patients
Enrollment Count:
101
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 60962 |
Who Masked List: